[ad_1]
The coronavirus vaccine has been completed on a historic schedule due to President Trump, Health and Human Services Secretary Alex Azar said on Monday.
“Think about this: 10 months after the start of this pandemic hitting our shores, thanks to what President Trump has done, we believe millions of people are going to be vaccinated before Christmas this year. It is simply unheard of in the history of public health, this accomplishment, ”Azar told“ Fox & Friends ”.
Azar said the vaccine would be “shipped” within 24 hours of FDA approval and then it would be up to “nursing homes, hospitals and pharmacies to get it released.”
“It could really be that within days of FDA approval, we would start to see vaccines on people’s arms, which is frankly amazing,” Azar said.
LIVE UPDATES: MODERNA SUBMIT CORONAVIRUS VACCINE FOR EMERGENCY USE AUTHORIZATION
Moderna has become the latest company to announce that it will seek emergency use authorization for its coronavirus vaccine candidate.
In a statement regarding plans to file for emergency clearance, the company said it expects to have up to 20 million doses available by the end of 2020, and up to 1 billion doses available worldwide by 2021. The shot, which is a two-dose jab, would be ready to ship within weeks of approval, according to the company.
Pfizer has already filed for emergency clearance and the FDA plans to make a decision in early December. AstraZeneca has also indicated that it is preparing to file an emergency use authorization.
There have been more than 13.3 million confirmed cases of the virus in the United States since the start of the pandemic, according to Johns Hopkins University.
CLICK HERE TO GET THE FOX NEWS APP
Moderna has announced that it will seek authorization for emergency use of its coronavirus vaccine. This will make it the second company to do so. Pfizer had already applied for an emergency clearance. The FDA plans to make a decision by early December.
“Pfizer submitted its request a week ago and the FDA announced that it would hold a public advisory committee hearing on December 10. Then, if everything is on track, the FDA could approve within days of this hearing, then Moderna. They have filed today and there will be an advisory committee for them probably on December 17th is what the company announced, ”Azar said. “And again, it could be that in the days following this public advisory committee, the FDA will grant its approval if the data all confirms its appearance.
The other candidate, who belongs to Moderna, is also promising, he said.
“And the data from Moderna is incredible today – 30,000 people are in the clinical trial and they just published their full results: 94% effectiveness,” Azar said. “It’s incredible.”
[ad_2]
Source link